quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:05:36·486d
SECFiling
Translational Development Acquisition Corp. logo

SEC Form 424B4 filed by Trident Acquisitions Corp.

TDAC· Translational Development Acquisition Corp.
Full content unavailable. See the original source below.
Original source

Companies

  • TDAC
    Translational Development Acquisition Corp.

Recent analyst ratings

  • Sep 21UpdateNorthland Capital Markets$16.00

Related

  • SEC24d
    SEC Form 10-K filed by Translational Development Acquisition Corp.
  • SEC160d
    SEC Form 10-Q filed by Translational Development Acquisition Corp.
  • SEC195d
    Amendment: SEC Form SCHEDULE 13G/A filed by Translational Development Acquisition Corp.
  • SEC252d
    Translational Development Acquisition Corp. filed SEC Form 8-K: Creation of a Direct Financial Obligation, Other Events, Financial Statements and Exhibits
  • SEC252d
    SEC Form 10-Q filed by Translational Development Acquisition Corp.
  • SEC266d
    Amendment: SEC Form SCHEDULE 13G/A filed by Translational Development Acquisition Corp.
  • SEC286d
    Amendment: SEC Form SCHEDULE 13G/A filed by Translational Development Acquisition Corp.
  • SEC343d
    SEC Form 10-Q filed by Translational Development Acquisition Corp.
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022